Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Hyaluronan open-pit nanofibrils with spontaneous cell-matrix assembly for advanced osteochondral defect repair.

Bui HD., Kim H., Pham-Nguyen OV., Mao W., Kang BJ., Yoo HS.

Animal Study on Cartilage Damage, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mater Today Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41852880
PMCID
PMC12993008
DOI
10.1016/j.mtbio.2026.102986

Abstract (original English)

While hyaluronic acid (HA) inherently promotes chondrogenesis, its hydrophilic character and lack of receptor-specific ligands impede robust cell adhesion - underscoring the need for nanofibrous matrices that emulate the extracellular microenvironment to enhance cell - matrix interactions. Therefore, we designed HA-based nanofibrils (NFs) with a high capability of self-assembly with adipose - derived stem cells (ADSCs) to enhance cell - matrix interaction, thereby promoting chondrogenesis. To address the electrospinning challenges arising from the high viscosity and hydrophilicity of hyaluronic acid (HA), a co-axial electrospinning technique was employed to fabricate core - sheath nanofibers consisting of a polycaprolactone (PCL)/poly(ethylene glycol) (PEG) sheath and an HA core (PCL/PEG@HA nanofibers). After chemical crosslinking of the HA core and the following etching of PEG on the sheath, the engineered nanofibers exhibited considerable HA displays on the surfaces (PCL@HA nanofibers). The fragmented nanofibers (PCL@HA NFs) could be self-assembled into cells - NFs matrix with ADSCs. Owing to HA exposure on the NFs, ADSCs exhibited higher cell proliferation and enhanced chondrogenic differentiation when the spontaneously assembled matrix of ADSCs - PCL@HA NFs was incubated in a reduced chondrogenic medium. In vivo investigations also validated the chondrogenic effects of PCL@

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research